Tukysa

E2049903 UNEXPLORED

Tukysa is a targeted cancer therapy (tucatinib) used primarily to treat HER2-positive breast cancer, developed and marketed by Seagen.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
Tukysa canonical 2

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Seagen → hasProduct → Tukysa ⓘ
tucatinib → hasTradeName → Tukysa ⓘ